共 50 条
- [31] Characterizing Radiographic and Pathologic Outcomes After Stereotactic Body Radiation Therapy (SBRT) in the Management of Primary Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S380 - S380
- [33] Dynamic CT Appearance of Tumor Response and Radiation Injury of the Liver after Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S356 - S356
- [35] Central Hepatobiliary Tree As an Organ at Risk for Stereotactic Body Radiation Therapy (SBRT) of the Liver: Is It High Priority for Hepatocellular Carcinoma (HCC)? INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E60 - E60
- [36] Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (04): : 900 - 909
- [37] Stereotactic Body Radiation Therapy (SBRT) Combined With Transarterial Chemoembolization (TACE) in BCLC Stage B and C Hepatocellular Carcinoma (HCC) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E162 - E162
- [38] Stereotactic Body Radiation Therapy (SBRT) With Functional Treatment Planning for Hepatocellular Carcinoma (HCC) in Patients With Early-Stage Cirrhosis INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E182 - E182
- [39] Phase 1/2 Trial of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Cirrhotic Patients INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E161 - E161